Drug Price Trends for CARDIZEM CD

Average Pharmacy Cost for CARDIZEM CD

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
CARDIZEM CD 120 MG CAPSULE	00187-0795-30	27.23083	EACH	2025-03-19
CARDIZEM CD 120 MG CAPSULE	00187-0795-42	27.23083	EACH	2025-03-19
CARDIZEM CD 240 MG CAPSULE	00187-0797-30	46.66267	EACH	2025-03-19
CARDIZEM CD 240 MG CAPSULE	00187-0797-42	46.66267	EACH	2025-03-19
CARDIZEM CD 240 MG CAPSULE	00187-0797-30	46.66267	EACH	2025-02-19
CARDIZEM CD 240 MG CAPSULE	00187-0797-42	46.66267	EACH	2025-02-19

Market Analysis and Price Projections for CARDIZEM CD

Market Overview

The market for CARDIZEM CD, a formulation of the calcium channel blocker diltiazem, is poised for significant growth driven by several key factors.

Increasing Incidence of Cardiovascular Diseases

The rise in cardiovascular disease incidence, particularly among the elderly population, is a major driver of the diltiazem market. As the global population ages, the prevalence of heart diseases such as hypertension, angina, and heart failure increases, leading to a higher demand for medications like CARDIZEM CD[1][3].

Growing Elderly Population

The elderly population is more prone to cardiovascular diseases due to structural and functional changes in the cardiovascular system associated with aging. This demographic shift is expected to bolster the growth of the diltiazem market, including CARDIZEM CD[1][3].

Market Size and Growth Projections

• Global Market: The global diltiazem market is projected to grow from $369.95 million in 2021 to $832.51 million by 2028, at a Compound Annual Growth Rate (CAGR) of 12.3% from 2021 to 2028[1].
• North America Market: In North America, the diltiazem market is expected to reach $369.22 million by 2028 from $161.53 million in 2021, growing at a CAGR of 12.5% during the same period[3].

Product Segmentation

The diltiazem market, including CARDIZEM CD, is segmented into capsules, injections, and tablets.

• Tablets Segment: In 2021, the tablets segment held the largest share of the market. However, the capsules segment, which includes CARDIZEM CD, is expected to witness the fastest CAGR of 12.8% from 2021 to 2028[1][3].

Application Segmentation

The market is also segmented by application, with hypertension being the largest segment in 2021. However, the angina segment is expected to grow at the fastest CAGR in the coming years[3].

Pricing and Cost Analysis

CARDIZEM CD Prices

The cost of CARDIZEM CD varies based on the dosage and quantity.

• 120 mg/24 hours: The cost for a 30-day supply of CARDIZEM CD oral capsules (120 mg/24 hours) is around $908.34, with a per-unit cost of $30.28[2].
• 180 mg/24 hours: For a 30-day supply of 180 mg/24 hours capsules, the cost is approximately $1,143.31, with a per-unit cost of $38.11[2].
• 240 mg/24 hours: The cost for a 30-day supply of 240 mg/24 hours capsules is about $1,546.61, with a per-unit cost of $51.55[2].
• 300 mg/24 hours: For a 30-day supply of 300 mg/24 hours capsules, the cost is around $2,022.91, with a per-unit cost of $67.43[2].

Generic and Brand Pricing

Generic versions of diltiazem are available and significantly cheaper than the brand-name CARDIZEM CD. For example, generic diltiazem prices start from $36.24 for 100 tablets, compared to $683.30 for 100 brand-name Cardizem 30 mg tablets[5].

Market Dynamics

Drivers

• Increase in Cardiovascular Disease Incidence: The rising incidence of cardiovascular diseases is a primary driver of the market.
• Increasing Elderly Population: The growing elderly population, which is more susceptible to heart diseases, drives the demand for diltiazem.
• Government Initiatives: Government initiatives for promoting healthcare and managing cardiovascular diseases also contribute to market growth[1][3].

Restraints

• Side Effects of Diltiazem: The side effects associated with diltiazem, such as postural hypotension and potential interactions with other medications, can hamper market growth[1][3].

Future Trends

Recent Developments

The COVID-19 pandemic has had a positive impact on the diltiazem market, as pharmaceutical companies have accelerated the development of drugs to combat the pandemic and its associated health issues. This trend is expected to continue, driving innovation and growth in the market[3].

Impact Analysis

The market is expected to benefit from advancements in drug formulations and delivery systems, such as extended-release capsules like CARDIZEM CD, which offer better patient compliance and therapeutic outcomes[4].

Key Players

The diltiazem market, including CARDIZEM CD, is dominated by several major pharmaceutical companies:

• Bausch Health
• Teva Pharmaceutical Industries Ltd
• Mylan N.V
• Athenex
• Pfizer, Inc
• Glenmark
• Sandoz (Novartis Ag)
• Sun Pharmaceutical Company Ltd
• Hikma Pharmaceuticals
• Zydus Pharmaceuticals[1].

Conclusion

The market for CARDIZEM CD is poised for significant growth, driven by the increasing incidence of cardiovascular diseases and the growing elderly population. While side effects may pose some challenges, the overall trend indicates a strong future for this medication.

Key Takeaways

• The global diltiazem market is projected to grow at a CAGR of 12.3% from 2021 to 2028.
• The North America diltiazem market is expected to reach $369.22 million by 2028.
• The capsules segment, including CARDIZEM CD, is expected to witness the fastest CAGR.
• Hypertension is the largest application segment, but the angina segment is growing rapidly.
• Generic versions of diltiazem are significantly cheaper than brand-name options.
• Side effects and interactions are key restraints to market growth.

FAQs

What is CARDIZEM CD used for?

CARDIZEM CD is used for the treatment of hypertension and the management of chronic stable angina and angina due to coronary artery spasm[4].

How much does CARDIZEM CD cost?

The cost of CARDIZEM CD varies by dosage; for example, a 30-day supply of 120 mg/24 hours capsules costs around $908.34[2].

Is there a generic version of CARDIZEM CD?

Yes, generic versions of diltiazem are available and are significantly cheaper than the brand-name CARDIZEM CD[5].

What are the main drivers of the diltiazem market?

The main drivers are the increasing incidence of cardiovascular diseases and the growing elderly population[1][3].

Which segment is expected to grow the fastest in the diltiazem market?

The capsules segment, which includes CARDIZEM CD, is expected to witness the fastest CAGR from 2021 to 2028[1][3].

What are the potential side effects of diltiazem?

Potential side effects include postural hypotension, and there may be interactions with other medications[1][3].

Sources

1. The Insight Partners: Diltiazem Market Size, Share & Growth Analysis by 2028
2. Drugs.com: Cardizem CD Prices, Coupons, Copay Cards & Patient Assistance
3. Business Market Insights: North America Diltiazem Market report 2028
4. Drugs.com: Cardizem CD: Package Insert / Prescribing Information
5. Drugs.com: Cardizem Prices, Coupons, Copay Cards & Patient Assistance